Free Trial
OTCMKTS:OCPNY

Olympus (OCPNY) Stock Price, News & Analysis

Olympus logo
$18.00 -0.25 (-1.37%)
As of 01/31/2023

About Olympus Stock (OTCMKTS:OCPNY)

Key Stats

Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$16.80
$74.99
Volume
400 shs
Average Volume
860,265 shs
Market Capitalization
$23.15 billion
P/E Ratio
21.95
Dividend Yield
0.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Receive OCPNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.

OCPNY Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Elon Musk has done it again. He’s developed a powerful new AI model that’s already turning heads — and turning the industry upside down. Some say it could threaten Google’s search engine dominance. Others believe it could mark the beginning of the end for ChatGPT.
See More Headlines

OCPNY Stock Analysis - Frequently Asked Questions

Olympus' stock was trading at $18.00 on January 1st, 2025. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00.
View the best growth stocks for 2025 here
.

Olympus Co. (OTCMKTS:OCPNY) issued its quarterly earnings results on Thursday, August, 5th. The company reported $0.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.10 by $0.03. The company had revenue of $1.75 billion for the quarter, compared to analysts' expectations of $1.49 billion. Olympus had a trailing twelve-month return on equity of 24.30% and a net margin of 13.80%.

Olympus subsidiaries include these companies: FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and more.

Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/05/2021
Today
4/25/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Structural clay products
Sub-Industry
N/A
Current Symbol
OTCMKTS:OCPNY
CIK
N/A
Employees
31,557
Year Founded
1919

Profitability

Trailing P/E Ratio
21.95
Forward P/E Ratio
10.91
P/E Growth
1.07
Net Income
$1.03 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.74 billion
Cash Flow
$1.22 per share
Price / Cash Flow
14.76
Book Value
$3.50 per share
Price / Book
5.14

Miscellaneous

Outstanding Shares
1,285,890,000
Free Float
N/A
Market Cap
$23.15 billion
Optionable
Not Optionable
Beta
0.70

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:OCPNY) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners